| Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia. EK Laverdière I, Boileau M, Neumann AL, Frison H, Mitchell A, Ng SWK, Wang ... Blood Cancer J. 8 (6), 52, 2018 | 83 | 2018 |
| Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression É Lévesque, SP Huang, É Audet-Walsh, L Lacombe, BY Bao, Y Fradet, ... Clinical Cancer Research 19 (3), 699-709, 2013 | 65 | 2013 |
| ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients S Chen, L Villeneuve, D Jonker, F Couture, I Laverdière, E Cecchin, ... Pharmacogenetics and genomics 25 (12), 573-583, 2015 | 52 | 2015 |
| Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer SP Huang, E Lévesque, C Guillemette, CC Yu, CY Huang, VC Lin, ... International journal of cancer 135 (11), 2661-2667, 2014 | 52 | 2014 |
| Human organ-specific 3D cancer models produced by the stromal self-assembly method of tissue engineering for the study of solid tumors V Roy, B Magne, M Vaillancourt-Audet, M Blais, S Chabaud, E Grammond, ... BioMed research international 2020, 2020 | 37 | 2020 |
| Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway É Lévesque, I Laverdiere, É Audet-Walsh, P Caron, M Rouleau, Y Fradet, ... Clinical Cancer Research 20 (11), 2971-2983, 2014 | 37 | 2014 |
| Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation E Lévesque, V Ménard, I Laverdière, J Bellemare, O Barbier, H Girard, ... Pharmacogenetics and genomics 20 (3), 195-210, 2010 | 36 | 2010 |
| In vitro investigation of human UDP-glucuronosyltransferase isoforms responsible for tacrolimus glucuronidation: predominant contribution of UGT1A4 I Laverdière, P Caron, M Harvey, É Lévesque, C Guillemette Drug Metabolism and Disposition 39 (7), 1127-1130, 2011 | 33 | 2011 |
| Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer É Lévesque, I Laverdiere, L Lacombe, P Caron, M Rouleau, V Turcotte, ... Clinical Cancer Research 20 (3), 576-584, 2014 | 30 | 2014 |
| Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice C Petit, A Croisetière, F Chen, I Laverdière Pharmacogenomics 21 (4), 247-256, 2020 | 29 | 2020 |
| Liquid chromatography–coupled tandem mass spectrometry based assay to evaluate inosine-5′-monophosphate dehydrogenase activity in peripheral blood mononuclear cells from stem … I Laverdière, P Caron, F Couture, C Guillemette, E Lévesque Analytical chemistry 84 (1), 216-223, 2012 | 29 | 2012 |
| A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients S Chen, I Laverdiere, A Tourancheau, D Jonker, F Couture, E Cecchin, ... The pharmacogenomics journal 15 (6), 513-520, 2015 | 27 | 2015 |
| A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients I Laverdière, P Caron, F Couture, É Lévesque, C Guillemette Journal of Chromatography B 885, 131-137, 2012 | 20 | 2012 |
| Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion L Frégeau-Proulx, A Lacouture, L Berthiaume, C Weidmann, M Harvey, ... Molecular Metabolism 62, 101516, 2022 | 18 | 2022 |
| Complement cascade gene expression defines novel prognostic subgroups of acute myeloid leukemia I Laverdière, M Boileau, T Herold, J Rak, WE Berdel, B Wörmann, ... Experimental hematology 44 (11), 1039-1043. e10, 2016 | 18 | 2016 |
| The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy I Laverdiere, C Flageole, É Audet-Walsh, P Caron, Y Fradet, L Lacombe, ... Endocrine-related cancer 22 (1), 77-85, 2015 | 12 | 2015 |
| A FACS-Free Purification Method to Study Estrogen Signaling, Organoid Formation, and Metabolic Reprogramming in Mammary Epithelial Cells A Lacouture, C Jobin, C Weidmann, L Berthiaume, D Bastien, I Laverdière, ... Frontiers in Endocrinology, 994, 2021 | 10 | 2021 |
| Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease I Laverdière, C Guillemette, R Tamouza, P Loiseau, RP de Latour, ... haematologica 100 (2), 275, 2015 | 5* | 2015 |
| Parents’ Experiences with Home-Based Oral Chemotherapy Prescribed to a Child Diagnosed with Acute Lymphoblastic Leukemia: A Qualitative Study É Camiré-Bernier, E Nidelet, A Baghdadli, G Demers, MC Boulanger, ... Current Oncology 28 (6), 4377-4391, 2021 | 3 | 2021 |
| Identification of existing bioactive molecules that target acute myeloid leukemia stem cells M Boileau, I Laverdière, A Mitchell, SWK Ng, JCY Wang, MD Minden, ... Experimental Hematology 44 (9), S60-S61, 2016 | 3 | 2016 |
